Cleo Diagnostics Ltd has released a press release.
CLEO Significantly Expands Addressable Market
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CLEO Diagnostics
- CLEO Successfully Completes Stage 1 MDSAP Audit
- Cleo Receives Positive FDA Feedback
- Appendix 4E and 2025 Annual Report
- COV Commences Health Economic Study-Support US Market Entry
- CLEO Strengthens FDA Submission - Access to US Biobank
Later from CLEO Diagnostics
- CLEO Appoints First Key Opinion Leader to Support US Market
- Cleo Strengthens Cash Position with $1.7m R&D Tax Refund
- Trading Halt
- CLEO Raises $5m to Support U.S. Market Launch
- Quarterly activities and cashflow report
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics